Optimal management of residual mass after chemotherapy in advanced seminoma: There is time for everything .
Value in Health.
Times cited: 13
Adjuvant chemotherapy in pathologic stage II nonseminomatous testicular cancer: Are two cycles of etoposide-cisplatin a standard option? .
Journal of Clinical Oncology.
Times cited: 1
Prognostic factors in metastatic germ cell tumors.
Progress in clinical and biological research.
Times cited: 7